Loading…
Circulating Sestrin Levels Are Increased in Hypertension Patients
Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertensi...
Saved in:
Published in: | Disease markers 2020, Vol.2020 (2020), p.1-8 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03 |
---|---|
cites | cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03 |
container_end_page | 8 |
container_issue | 2020 |
container_start_page | 1 |
container_title | Disease markers |
container_volume | 2020 |
creator | Lin, Ying-zhong Liu, Ling Shi, Ying Zeng, Tao Shi, Lei Yang, Zicong Fang, Cao Liu, Hongtao |
description | Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension. |
doi_str_mv | 10.1155/2020/3787295 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7306853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A632853497</galeid><sourcerecordid>A632853497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</originalsourceid><addsrcrecordid>eNqNkd1LHDEUxUOx1NX61ucy4EvBjub740VYlrYKCxVan0Mmc2eNzGbWZMbif98su9XWpz6EC8nvnpPDQegDweeECHFBMcUXTGlFjXiDZkQrUWvJ8AGaYap0jSnHh-go53uMCTXcvEOHjEoqBSczNF-E5KfejSGuqh-QxxRitYRH6HM1T1BdR5_AZWircn_1tIE0QsxhiNVN2YE45vfobef6DCf7eYxuv375ubiql9-_XS_my9pzY8aaauk5EENYa1rZOco05Y5TibtGKzBKENZ47DnjDVdGe1C-aRWmnnSkc5gdo8ud7mZq1tD64p1cbzcprF16soML9t-XGO7sani0imGpBSsCn_YCaXiYSlS7DtlD37sIw5Qt5RTLcrgo6Okr9H6YUizxCkUEJUJq80KtXA82xG4ovn4raueS0eLJjSrU5x3l05Bzgu75ywTbbYN226DdN1jwj3_HfIb_VFaAsx1wF2LrfoX_lIPCQOdeaCJKA4r9Bo7rqzc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2415215689</pqid></control><display><type>article</type><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao</creator><contributor>Dugue, Benoit ; Benoit Dugue</contributor><creatorcontrib>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao ; Dugue, Benoit ; Benoit Dugue</creatorcontrib><description>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2020/3787295</identifier><identifier>PMID: 32626541</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adult ; Age ; Angiotensin ; Angiotensin II ; Aorta ; Arteriosclerosis ; Atherosclerosis ; Autophagy ; Biomarkers - blood ; Blood pressure ; Body mass index ; Cardiovascular disease ; Cardiovascular diseases ; Case-Control Studies ; Cholesterol ; Comparative analysis ; Congestive heart failure ; Creatinine ; Enzyme-linked immunosorbent assay ; Enzymes ; Female ; Heart failure ; Heart rate ; Heat-Shock Proteins - blood ; Hemoglobin ; Homocysteine ; Humans ; Hypertension ; Hypertension - blood ; Levels ; Lipoproteins ; Male ; Middle Aged ; Nuclear Proteins - blood ; Oxidative stress ; Patients ; Plasma ; Plasma levels ; Regression analysis ; Risk Factors ; Severity of Illness Index ; Studies ; Triglycerides ; Up-Regulation</subject><ispartof>Disease markers, 2020, Vol.2020 (2020), p.1-8</ispartof><rights>Copyright © 2020 Cao Fang et al.</rights><rights>COPYRIGHT 2020 John Wiley & Sons, Inc.</rights><rights>Copyright © 2020 Cao Fang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Cao Fang et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</citedby><cites>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</cites><orcidid>0000-0003-4424-0340 ; 0000-0003-3790-6159 ; 0000-0001-9822-1423</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32626541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Dugue, Benoit</contributor><contributor>Benoit Dugue</contributor><creatorcontrib>Lin, Ying-zhong</creatorcontrib><creatorcontrib>Liu, Ling</creatorcontrib><creatorcontrib>Shi, Ying</creatorcontrib><creatorcontrib>Zeng, Tao</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><creatorcontrib>Yang, Zicong</creatorcontrib><creatorcontrib>Fang, Cao</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</description><subject>Adult</subject><subject>Age</subject><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Aorta</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Autophagy</subject><subject>Biomarkers - blood</subject><subject>Blood pressure</subject><subject>Body mass index</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Case-Control Studies</subject><subject>Cholesterol</subject><subject>Comparative analysis</subject><subject>Congestive heart failure</subject><subject>Creatinine</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Female</subject><subject>Heart failure</subject><subject>Heart rate</subject><subject>Heat-Shock Proteins - blood</subject><subject>Hemoglobin</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - blood</subject><subject>Levels</subject><subject>Lipoproteins</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nuclear Proteins - blood</subject><subject>Oxidative stress</subject><subject>Patients</subject><subject>Plasma</subject><subject>Plasma levels</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Studies</subject><subject>Triglycerides</subject><subject>Up-Regulation</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkd1LHDEUxUOx1NX61ucy4EvBjub740VYlrYKCxVan0Mmc2eNzGbWZMbif98su9XWpz6EC8nvnpPDQegDweeECHFBMcUXTGlFjXiDZkQrUWvJ8AGaYap0jSnHh-go53uMCTXcvEOHjEoqBSczNF-E5KfejSGuqh-QxxRitYRH6HM1T1BdR5_AZWircn_1tIE0QsxhiNVN2YE45vfobef6DCf7eYxuv375ubiql9-_XS_my9pzY8aaauk5EENYa1rZOco05Y5TibtGKzBKENZ47DnjDVdGe1C-aRWmnnSkc5gdo8ud7mZq1tD64p1cbzcprF16soML9t-XGO7sani0imGpBSsCn_YCaXiYSlS7DtlD37sIw5Qt5RTLcrgo6Okr9H6YUizxCkUEJUJq80KtXA82xG4ovn4raueS0eLJjSrU5x3l05Bzgu75ywTbbYN226DdN1jwj3_HfIb_VFaAsx1wF2LrfoX_lIPCQOdeaCJKA4r9Bo7rqzc</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Lin, Ying-zhong</creator><creator>Liu, Ling</creator><creator>Shi, Ying</creator><creator>Zeng, Tao</creator><creator>Shi, Lei</creator><creator>Yang, Zicong</creator><creator>Fang, Cao</creator><creator>Liu, Hongtao</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TK</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4424-0340</orcidid><orcidid>https://orcid.org/0000-0003-3790-6159</orcidid><orcidid>https://orcid.org/0000-0001-9822-1423</orcidid></search><sort><creationdate>2020</creationdate><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><author>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Age</topic><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Aorta</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Autophagy</topic><topic>Biomarkers - blood</topic><topic>Blood pressure</topic><topic>Body mass index</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Case-Control Studies</topic><topic>Cholesterol</topic><topic>Comparative analysis</topic><topic>Congestive heart failure</topic><topic>Creatinine</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Female</topic><topic>Heart failure</topic><topic>Heart rate</topic><topic>Heat-Shock Proteins - blood</topic><topic>Hemoglobin</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - blood</topic><topic>Levels</topic><topic>Lipoproteins</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nuclear Proteins - blood</topic><topic>Oxidative stress</topic><topic>Patients</topic><topic>Plasma</topic><topic>Plasma levels</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Studies</topic><topic>Triglycerides</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Ying-zhong</creatorcontrib><creatorcontrib>Liu, Ling</creatorcontrib><creatorcontrib>Shi, Ying</creatorcontrib><creatorcontrib>Zeng, Tao</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><creatorcontrib>Yang, Zicong</creatorcontrib><creatorcontrib>Fang, Cao</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Ying-zhong</au><au>Liu, Ling</au><au>Shi, Ying</au><au>Zeng, Tao</au><au>Shi, Lei</au><au>Yang, Zicong</au><au>Fang, Cao</au><au>Liu, Hongtao</au><au>Dugue, Benoit</au><au>Benoit Dugue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating Sestrin Levels Are Increased in Hypertension Patients</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32626541</pmid><doi>10.1155/2020/3787295</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4424-0340</orcidid><orcidid>https://orcid.org/0000-0003-3790-6159</orcidid><orcidid>https://orcid.org/0000-0001-9822-1423</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-0240 |
ispartof | Disease markers, 2020, Vol.2020 (2020), p.1-8 |
issn | 0278-0240 1875-8630 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7306853 |
source | Open Access: Wiley-Blackwell Open Access Journals |
subjects | Adult Age Angiotensin Angiotensin II Aorta Arteriosclerosis Atherosclerosis Autophagy Biomarkers - blood Blood pressure Body mass index Cardiovascular disease Cardiovascular diseases Case-Control Studies Cholesterol Comparative analysis Congestive heart failure Creatinine Enzyme-linked immunosorbent assay Enzymes Female Heart failure Heart rate Heat-Shock Proteins - blood Hemoglobin Homocysteine Humans Hypertension Hypertension - blood Levels Lipoproteins Male Middle Aged Nuclear Proteins - blood Oxidative stress Patients Plasma Plasma levels Regression analysis Risk Factors Severity of Illness Index Studies Triglycerides Up-Regulation |
title | Circulating Sestrin Levels Are Increased in Hypertension Patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A19%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20Sestrin%20Levels%20Are%20Increased%20in%20Hypertension%20Patients&rft.jtitle=Disease%20markers&rft.au=Lin,%20Ying-zhong&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2020/3787295&rft_dat=%3Cgale_pubme%3EA632853497%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2415215689&rft_id=info:pmid/32626541&rft_galeid=A632853497&rfr_iscdi=true |